triumph-1 trial retatrutide does more than activate GLP- 1. It targets three metabolic pathways:, GLP-1, GIP, Glucagon, In the Phase 3 trial, the highest-dose group lost an average of 28.3% of their body retatrutide phase 2 obesity trial
Pay in 4 interest-free payments of $6.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28


























